Ares Capital Management does not own any shares in Telomir Pharmaceuticals (TELO). The owners of Ares Capital Markets Group have been compensated Forty-Thousand Dollars Cash ($40,000) via bank wire transfer from a third party (Spark Newswire) for a 14 day Marketing Program regarding TELO with a start date of 05/5/2024 - 05/19/2024